Evidence map›Paper›PMID 24882734›Full record

ReviewBone2014

Anorexia nervosa and bone metabolism.

Pouneh K Fazeli, Anne Klibanski

Abstract readReview
In one paragraph

Review in Bone, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  9. Review
  10. Review
  11. Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Pouneh K FazeliNeuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: pkfazeli@partners.org.
Anne KlibanskiNeuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Massachusetts General Hospital · US

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI STEVEN K. GRINSPOON · 1994 to 2026
$31.6M
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy BalanceR24DK092759 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, MACDOUGALD, ORMOND A · 2011 to 2019
$13.0M
The Role of PTH in the Low Bone Mass of Anorexia NervosaK23DK094820 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FAZELI, POUNEH KHADEJEH · 2012 to 2015
$746k
NIDDK NIH HHS K23 DK094820NIDDK NIH HHS P30 DK040561NIDDK NIH HHS R24 DK092759
6 · The paper itself

Abstract

Anorexia nervosa (AN) is a psychiatric disorder characterized by self-induced starvation with a lifetime prevalence of 2.2% in women. The most common medical co-morbidity in women with AN is bone loss, with over 85% of women having bone mineral density values more than one standard deviation below an age comparable mean. The low bone mass in AN is due to multiple hormonal adaptations to under nutrition, including hypothalamic amenorrhea and growth hormone resistance. Importantly, this low bone mass is also associated with a seven-fold increased risk of fracture. Therefore, strategies to effectively prevent bone loss and increase bone mass are critical. We will review hormonal adaptations that contribute to bone loss in this population as well as promising new therapies that may increase bone mass and reduce fracture risk in AN.

Indexed as

Anorexia NervosaBone and BonesBone DensityHumansOrgan SizeRisk FactorsAnorexia nervosaBone mineral density

Identifiers

PMID24882734
PMCPMC4125514
OpenAlexW2060600780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.